Stock Events

Stock Events

Hyloris Pharmaceuticals SA 

€4.30
0
-€0.04-0.92% Monday 19:56

Statistics

Day High
4.43
Day Low
4.29
52W High
8.1
52W Low
4.3
Volume
-
Avg. Volume
-
Mkt Cap
120.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25SepExpected
Q2 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-87.89%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.21MRevenue
-6.33MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 52U.STU. It's not an investment recommendation.
Colruyt Group N.V.
5
COLR.BR
Anheuser-Busch InBev SA/NV
4
ABI.BR
Ageas SA/NV
4
AGS.BR
Prosus NV
4
PRX.AS

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a global pharmaceutical company that competes with Hyloris in the development and marketing of medications across various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its pharmaceutical segment, competes in developing innovative healthcare solutions similar to Hyloris.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is a leading pharmaceutical company that develops drugs in areas that may overlap with Hyloris's product portfolio.
Novartis
NVS
Mkt Cap301.95B
Novartis AG is a multinational pharmaceutical company that competes with Hyloris in researching and marketing drugs in various therapeutic categories.
GSK
GSK
Mkt Cap104.97B
GlaxoSmithKline plc is a global healthcare company that competes with Hyloris in the pharmaceutical and healthcare market, focusing on a wide range of medical conditions.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie Inc. is a research-based biopharmaceutical company that competes with Hyloris in developing advanced therapies for complex health conditions.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a global biopharmaceutical company that develops prescription medicines, competing with Hyloris in several therapeutic areas.
Sanofi
SNY
Mkt Cap109.86B
Sanofi is a global healthcare leader that competes with Hyloris in the development and marketing of pharmaceuticals and vaccines.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare that competes with Hyloris in the pharmaceutical and diagnostics sectors.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca PLC is a global, science-led biopharmaceutical business that competes with Hyloris in developing and commercializing prescription medicines.

About

Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Show more...
CEO
Stijn Van Rompay
Employees
55
Country
Belgium
ISIN
BE0974363955
WKN
000A2P7Y0

Listings

STU
DE
52U.STU
BR
BE
HYL.BR
F
DE
52U.F
LSE
GB
0AB6.LSE

0 Comments

Share your thoughts

FAQ

What is Hyloris Pharmaceuticals SA stock price today?▼
The current price of 52U.STU is €4.30 EUR — it has decreased by -0.92% in the past 24 hours. Watch Hyloris Pharmaceuticals SA stock price performance more closely on the chart.
What is Hyloris Pharmaceuticals SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Hyloris Pharmaceuticals SA stocks are traded under the ticker 52U.STU.
Is Hyloris Pharmaceuticals SA stock price growing?▼
52U.STU stock has risen by +0% compared to the previous week, the month change is a -3.37% fall, over the last year Hyloris Pharmaceuticals SA has showed a -34.85% decrease.
What is Hyloris Pharmaceuticals SA market cap?▼
Today Hyloris Pharmaceuticals SA has the market capitalization of 120.4M
What is Hyloris Pharmaceuticals SA revenue for the last year?▼
Hyloris Pharmaceuticals SA revenue for the last year amounts to 7.21M EUR.
What is Hyloris Pharmaceuticals SA net income for the last year?▼
52U.STU net income for the last year is -6.33M EUR.
How many employees does Hyloris Pharmaceuticals SA have?▼
As of August 25, 2026, the company has 55 employees.
In which sector is Hyloris Pharmaceuticals SA located?▼
Hyloris Pharmaceuticals SA operates in the Health & Wellness sector.
When did Hyloris Pharmaceuticals SA complete a stock split?▼
Hyloris Pharmaceuticals SA has not had any recent stock splits.
Where is Hyloris Pharmaceuticals SA headquartered?▼
Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.